Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.

Burger CF, Schlesinger JJ.

Ann Pharmacother. 2014 Feb;48(2):286-91. doi: 10.1177/1060028013511060. Epub 2013 Nov 6.

PMID:
24259642
2.

Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.

Demma LJ, Paciullo CA, Levy JH.

J Thorac Cardiovasc Surg. 2012 May;143(5):1213-8. doi: 10.1016/j.jtcvs.2011.07.068. Epub 2012 Feb 11.

PMID:
22329977
3.

Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.

Hursting MJ, Lewis BE, Macfarlane DE.

Clin Appl Thromb Hemost. 2005 Jul;11(3):279-87.

PMID:
16015413
4.
6.

Current agents for the treatment of patients with heparin-induced thrombocytopenia.

Warkentin TE.

Curr Opin Pulm Med. 2002 Sep;8(5):405-12. Review.

PMID:
12172444
7.

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.

Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG; Argatroban-915 Investigators.

Arch Intern Med. 2003 Aug 11-25;163(15):1849-56.

PMID:
12912723
8.

Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.

Nanda MM, Kauflin MJ, Jain PG, Yannetta JC 3rd.

Ann Pharmacother. 2011 Mar;45(3):e16. doi: 10.1345/aph.1P709. Epub 2011 Mar 8.

PMID:
21386022
9.

Heparin-induced thrombocytopenia from venous thromboembolism treatment.

Begelman SM, Hursting MJ, Aghababian RV, McCollum D.

J Intern Med. 2005 Dec;258(6):563-72.

10.

Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.

Dee B, Lombardi Thomas L, Gulbis A.

Am J Health Syst Pharm. 2014 May 1;71(9):711-6. doi: 10.2146/ajhp130132. Erratum in: Am J Health Syst Pharm. 2014 Jul 15;71(14):1157.

PMID:
24733133
11.
12.

Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Hursting MJ, Soffer J.

Drug Saf. 2009;32(3):203-18. doi: 10.2165/00002018-200932030-00003. Review.

PMID:
19338378
13.

High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.

Hellwig TR, Peitz GJ, Gulseth MP.

Am J Health Syst Pharm. 2012 Mar 15;69(6):490-5. doi: 10.2146/ajhp110147.

PMID:
22382479
14.

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

Dager WE, White RH.

Ann Pharmacother. 2003 Sep;37(9):1232-6.

PMID:
12921505
15.

Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.

Yarbrough PM, Varedi A, Walker A, Rondina MT.

Ann Pharmacother. 2012 Nov;46(11):e30. doi: 10.1345/aph.1R226. Epub 2012 Oct 16.

16.

Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.

Kondo LM, Wittkowsky AK, Wiggins BS.

Ann Pharmacother. 2001 Apr;35(4):440-51. Review.

PMID:
11302409
17.
18.

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.

Saugel B, Phillip V, Moessmer G, Schmid RM, Huber W.

Crit Care. 2010;14(3):R90. doi: 10.1186/cc9024. Epub 2010 May 20. Erratum in: Crit Care. 2012;16(2):415.

19.

Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.

Wellborn-Kim JJ, Mitchell GA, Terneus WF Jr, Stowe CL, Malias MA, Sparkman GM, Hanson GW.

Am J Health Syst Pharm. 2010 Jul 1;67(13):1075-9. doi: 10.2146/ajhp090394.

PMID:
20554593
20.

The management of heparin-induced thrombocytopenia.

Keeling D, Davidson S, Watson H; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.

Br J Haematol. 2006 May;133(3):259-69. Erratum in: Br J Haematol. 2006 Aug;134(3):351.

PMID:
16643427
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk